McAllen Cancer Survivor Advocates for Clinical Trial Access

When Elvia Gibbs met Ashlynn in Washington D.C., all she could do was cry and say thank you—because Ashlynn's courage in a clinical trial led directly to the medication keeping Gibbs alive today.

Gibbs, a breast cancer survivor from McAllen, Texas, traveled to the nation's capital as an American Cancer Society Cancer Action Network volunteer. She met with lawmakers to advocate for increased federal funding for cancer research and improved access to clinical trials.

Her mission is deeply personal. Gibbs survived an aggressive form of breast cancer and now depends on medication developed through clinical trials. Without it, doctors told her there was an 80% chance her cancer could return within five years.

"This medication gives me my best fighting chance," Gibbs said. "Because of that research, I am able to have a quality of life I may not otherwise have. I am able to be present with my family, love on my husband, and look forward to another day of life."

Gibbs specifically advocated for the Clinical Trial Modernization Act, legislation designed to remove financial and geographic barriers that prevent patients from participating in potentially lifesaving research. For Rio Grande Valley residents, those barriers are significant.

South Texas patients often must travel three and a half hours to San Antonio or up to five hours to Houston to participate in clinical trials. For people undergoing cancer treatment, the cost of transportation, lodging, and other expenses can make participation impossible.

The proposed legislation would help cover costs associated with trial participation, including travel and lodging expenses. Gibbs said lawmakers she met committed to cosponsoring the bill, and she plans to follow up through district meetings, calls, and emails.

Why This Inspires

Gibbs proves that everyday people can create change by sharing their stories with decision-makers. Her willingness to speak up could help remove barriers that currently prevent countless patients from accessing cutting-edge treatments. And her emotional meeting with Ashlynn shows how clinical trial participants become part of a chain of hope, their courage directly saving lives they may never meet.

"There is no voice too small to speak up, share a story, and help create change," Gibbs said. "Every voice has the potential to make a difference, and every breakthrough can give someone more time."